← FDA Drug Approvals (Drugs@FDA)

ARIPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2022-10-27

Drug application

FDA Application #

ANDA216351

Application type

Abbreviated New Drug Application (Generic)

Brand name

ARIPIPRAZOLE

Generic name

ARIPIPRAZOLE

Active ingredients

ARIPIPRAZOLE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

RUBICON RESEARCH

Manufacturer

Advagen Pharma Ltd

First approval

2022-10-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown